CCL2: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 08:53, 10 February 2025
CCL2, also known as Monocyte Chemoattractant Protein 1 (MCP-1), is a small cytokine belonging to the CC chemokine family. CCL2 recruits monocytes, memory T cells, and dendritic cells to the sites of inflammation produced by either tissue injury or infection.
Structure
CCL2 is a monomeric polypeptide, with a molecular weight of approximately 13 kDa. The protein shares approximately 22-62% amino acid sequence homology with other CC chemokines.
Function
CCL2 is involved in the pathogenesis of several diseases characterized by monocytic infiltrates, such as psoriasis, rheumatoid arthritis and atherosclerosis. It is also known to be a potent inhibitor of HIV-1 by binding to the cellular protein, CCR5, which is the major co-receptor for macrophage-tropic strains of HIV-1.
Clinical significance
CCL2 has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It is also known to be a potent inhibitor of HIV-1 by binding to CCR5, which is the major co-receptor for macrophage-tropic strains of HIV-1.


